FDA Highlights: Rapamycin shows pre-clinical potential in pancreatic cancer
by Bruce Sylvester: Rapamycin appears to shrink one type of pancreatic cancer tumor and prevents it from spreading, researchers reported on August 3, 2014 in the journal Gut.
